Results 201 to 210 of about 173,582 (279)

Novel biomarkers for early detection of HCC in patients with MASLD or ALD. [PDF]

Hepatol Commun
Deodhar S, Jarrah M, Parikh ND, Al-Hasan M, Gopal P, Singal AG.   +5 more
europepmc   +1 more source

Rhetorics of Counternationalism: The Limitations of Digital Anti‐Hindutva in Combating Right‐Wing Extremism

Nations and Nationalism, EarlyView.
ABSTRACT How are online discourses in subissues within counternationalist movements constructed? This study better understands what comprises digital counternationalist dissent against right‐wing nationalism, finding that right‐wing nationalism's success can also be explained through limitations in counternationalist discourse.
Mohammad Amaan Siddiqui
wiley   +1 more source

Cervical yolk sac tumor: a case report and literature review. [PDF]

Front Oncol
Wang M, Xu S, Zhan Y, Fan B, Wu Y.
europepmc   +1 more source

AFP Level Finding [PDF]

, 2020
openaire   +1 more source

Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma

Liver International Communications, Volume 7, Issue 2, June 2026.
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yoshihide Ueda, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +53 more
wiley   +1 more source

Liver transplantation for hepatocellular carcinoma: from patient selection and downstaging to risk stratification and post-transplant surveillance. [PDF]

Gastroenterol Rep (Oxf)
Rezaee-Zavareh MS, Yang JD.
europepmc   +1 more source

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

International Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.
What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin, Li Zhu, Yuyang Huang, Lizhu Chen, Yuping Lu, Yu Chen, Jing Lin   +6 more
wiley   +1 more source

Serum protein induced by vitamin K absence or antagonist-II predicts aggressive tumor biology in alpha-fetoprotein-normal hepatocellular carcinoma. [PDF]

World J Gastrointest Oncol
Abbas Z, Gazder DP, Hyder Z, Qadeer MA, Abbas M.   +4 more
europepmc   +1 more source

Suicidal ideation in patients with atopic dermatitis: A case‐control study on 23,191 adults

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Julien Seneschal, Bruno Halioua, Jerry Tan, Chaoying Gu, Thomas Luger, Roni Dodiuk‐Gad, Roberto Takaoka, Flavia Pretti Aslanian, Cita Rosita Sigit Prakoeswa, Ann' Laure Demessant‐Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Abraham Getachew Kelbore, Laurent Misery, Therdpong Tempark, Alexander Stratigos, Martin Steinhoff, Jonathan I. Silverberg   +24 more
wiley   +1 more source

Addition of immune checkpoint inhibitors to intravesical BCG for high‐risk BCG‐naïve non‐muscle invasive bladder cancer: Systematic review and meta‐analysis

BJUI Compass, Volume 7, Issue 4, April 2026.
Abstract Objective The objective of this study is to assess the efficacy, safety and change in quality of life associated with ICI‐BCG (I + M) compared to BCG (I + M) in patients with BCG‐naïve HR‐NMIBC. Material and Methods A systematic search was run on PubMed, Embase and CENTRAL from inception to 29 October 2025. Phase 3 randomized controlled trials
Renil S. Titus, Carlos Riveros, Eusebio Luna Velasquez, David‐Dan Nguyen, Suran Somawardana, Amar Singh, Dharam Kaushik, Guru Sonpavde, Alexandre Zlotta, Girish Kulkarni, Srikala S. Sridhar, Christopher J. D. Wallis, Raj Satkunasivam   +12 more
wiley   +1 more source